🔗 Share this article

An underground market for unlicensed slimming drugs is being driven by TikTok fitness influencers and sellers on communication apps, according to new investigations.

Investigational Treatment Acquiring Popularity Via Social Media

The experimental drug, which is still in clinical trials, is being promoted by online personalities for its supposed fat-burning effects. Viewers are urged to message these profiles privately for supplier links, while also obtaining discount codes.

Thriving Commerce on Social Networks

Additionally, a robust market exists on Telegram, where groups with numerous of members share comparison images, injection guides and assertions of rapid UK delivery. Vendors market the substance there before directing buyers to other platforms for purchases.

Understanding Retatrutide

This medication is an investigational injectable created by American pharmaceutical company Eli Lilly. The treatment affects three intestinal hormones – GLP-1, GIP and glucagon. Early trials suggest it could help patients reduce up to 25% of their body weight. Referred to as the “triple G”, the substance is being promoted online as the next Ozempic.

Medical Professionals Voice Worries

However, doctors and chemists have cautions that the sale of what remains an unapproved medication in the United Kingdom is a cause for concern and could result in individuals injecting products of uncertain source.

Several experts stated the popularity for retatrutide could be linked to the increasing price of licensed weight loss treatments such as Mounjaro.

Legal Position and Enforcement

Marketing retatrutide on TikTok or messaging apps is prohibited in the UK, as it is an unapproved drug that must not be promoted or distributed for human use under the British medical regulations.

Several influencers attempt to circumvent the regulations by calling to the substance as a “research chemical” or describing it as “not for human consumption”. Retatrutide is not a controlled substance, but promotion and distribution can still breach pharmaceutical, advertising, and consumer regulations, risking fines, legal action or prison.

Service Reaction and Content Elimination

Based on the social media company, the service has removed problematic content and prohibited associated hashtags and query recommendations. The company said it was dedicated to maintaining the service secure and investing in strengthening compliance measures.

Online Marketplace Activities

Research also found groups with up to nine thousand participants selling the experimental drug using Telegram's built-in discovery tool, which functions like a public directory. Entering “retatrutide” immediately displays groups with thousands of members, filled with photos of slimming results, glowing testimonials and detailed guides for preparing or injecting at residence.

After minutes of entering one community, a vendor shared WhatsApp details, where the majority of transactions take place. The seller provided an guidebook and guaranteed shipping within two days. When asked whether the substance was authentic, one seller responded: “You can’t be sure.” Another provided a photo of a supposed laboratory certificate. None asked about weight, health issues or past usage.

Product Details and Pricing

Within these communities, posts show dark colored parcels with Royal Mail labels, claiming to include new batches. One communication read: “It took eight of us to load them this morning.”

Buyers can select between powder vials, prepared at home with purified liquid, or pre-filled injectors typically sold at £160 for 20 milligrams. When asked how long a pen should be used, sellers give conflicting answers ranging from a few weeks to “depends on your body”.

Platform Oversight and Security Actions

A representative for Telegram said it regularly monitored harmful material on its platform including content that encouraged the “misuse of controlled medications”. The company noted that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Warnings

“Individuals are administering substances they can’t verify. Even if the research behind retatrutide is sound, these online versions may not include what they advertise,” said a pharmacy expert, the head of pharmacy at Chemist4U.

A medical professional of an online medical service connected the surge in demand to recent price rises for approved slimming drugs such as Mounjaro. “With costs increasing, patients are turning to online platforms. But fake treatments are extremely dangerous. You cannot know what’s inside or whether the conditions they were made in was clean,” she said.

Her team has already encountered patients harmed by personal administration from unconfirmed sources. “We recognize the disappointment, but purchasing from Telegram or communication platforms is taking chances with your health,” said the doctor. “These substances could be contaminated or incorrectly dosed.”

Producer Statement

A spokesperson from Eli Lilly stated retatrutide was in third stage research studies and had not been reviewed or approved by any government authority globally. “Therefore at this point no one can sell [it] for human use,” they said, noting that any item “falsely representing itself as a company experimental substance not yet approved … may subject users to potentially significant health risks”.